US Drug Recall Register
Class II · Moderate risk Ongoing Initiated May 27, 2026 (3 months ago)

Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.

What was recalled

Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.

Recalling firm
Lannett Company Inc.
NDC code
62175-322-46
Origin
IN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0584-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Niacin recalls

See all